BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3740128)

  • 1. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis.
    Wanner C; Förstner-Wanner S; Schaeffer G; Schollmeyer P; Hörl WH
    Am J Nephrol; 1986; 6(3):206-11. PubMed ID: 3740128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of carnitine in patients with renal insufficiency.
    Wanner C; Hörl WH
    Klin Wochenschr; 1986 Jul; 64(13):579-86. PubMed ID: 3091903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.
    Moorthy AV; Rosenblum M; Rajaram R; Shug AL
    Am J Nephrol; 1983; 3(4):205-8. PubMed ID: 6614070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients.
    Constantin-Teodosiu D; Kirby DP; Short AH; Burden RP; Morgan AG; Greenhaff PL
    Kidney Int; 1996 Jan; 49(1):158-62. PubMed ID: 8770962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of different carnitine levels for improving the prognosis of patients undergoing hemodialysis.
    Zhang YM; Zhuo L; Hu J; Cui G; Zhang L; Zhang XL; Li WG
    Ren Fail; 2016 Nov; 38(10):1654-1658. PubMed ID: 27758157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
    Alhomida AS
    Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of kidney transplantation on carnitine metabolism.
    Kohse KP; Dech E; Rössle C; Franz HE; Fürst P
    Clin Nephrol; 1988 Apr; 29(4):199-205. PubMed ID: 3284670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carnitine levels according to the peritoneal equilibration test in patients on continuous ambulatory peritoneal dialysis.
    Chatzidimitriou C; Pliakogiannis T; Evangeliou A; Tsalkidou T; Böhles HJ; Kalaitzidis K
    Perit Dial Int; 1993; 13 Suppl 2():S444-7. PubMed ID: 8399636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
    Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
    Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
    Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
    Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis.
    Pliakogiannis T; Chatzidimitriou C; Evangeliou A; Böhles HJ; Kalaitzidis K
    Perit Dial Int; 1993; 13 Suppl 2():S440-3. PubMed ID: 8399635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.
    Di Liberato L; Arduini A; Rossi C; Di Castelnuovo A; Posari C; Sacchetta P; Urbani A; Bonomini M
    J Nephrol; 2014 Dec; 27(6):699-706. PubMed ID: 24599831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors.
    Kumagai E; Hosohata K; Furumachi K; Takai S
    Ther Apher Dial; 2021 Oct; 25(5):595-606. PubMed ID: 33470531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Content of thiamin in plasma and erythrocytes in patients with end stage renal disease].
    Pietrzak I; Baczyk K; Młynarczyk M; Kaczmarek M
    Przegl Lek; 1996; 53(5):423-6. PubMed ID: 8754406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.